Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) |
Stages | Expansion, Later Stage, MBO/LBO |
Investing | United States • India • China • Singapore • Hong Kong • Taiwan • Korea |
Investment Range | $40,000,000 - $200,000,000 |
Assets Under Management | $1,500,000,000 |
Stone Point Capital LLC is a private equity fund headquartered in the Henley Building at 5 Queens Road Central in Central, Hong Kong. They specialize in Expansion, Later Stage investments, as well as Management Buyouts and Leveraged Buyouts (MBO/LBO). Stone Point Capital targets companies within the Biotech, FinTech (& Financial Services), and HealthTech (& Fitness) industries. They are equipped with deep domain expertise in equity investments and hold significant experience in nurturing growth and expansion in their portfolio companies. Stone Point Capital is active in managing their investments with an assets under management (AUM) worth approximately $1,500,000,000. The fund typically invests between $40,000,000 and $200,000,000 in their portfolio companies, emphasizing the creation of long-term value through strategic and operational improvements. The firm operates with a commitment to partnering with companies poised for outstanding growth and market leadership, leveraging their industry expertise and extensive network to aid in the development of these businesses. While their website states that HPEF Capital Partners Limited's services are not available to the general public but rather a limited number of private investment vehicles, it should be noted that HPEF Capital Partners Limited's website content is included in the firm's description due to the provided URL and seems to be related to Stone Point Capital LLC.